Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
icosapent ethyl (vascepa) (1 trial)
Cholestasis (Phase 3)
Liver Diseases (Phase 3)
Trials (1 total)
Trial APIs (1 total)